Recipients of 2012 SAFE-Biopharma Digi Award named

Monday, April 30, 2012 04:52 PM

Recipients have been selected for the 2012 SAFE-BioPharma Digi Award, recognizing innovative uses of the global SAFE-BioPharma digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits. Recipients included: Astellas, Bristol-Myers Squibb and representatives of two U.S. government entities.

“The selected companies and individuals have helped advance the use and understanding of SAFE-BioPharma as a way to ensure trust in online identities and to apply legally-binding digital signatures to electronic documents,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. The board of directors of the non-profit consortium made the selections from nominations submitted from the biopharmaceutical, healthcare and information security sectors.

Astellas Pharma was selected for a SAFE-BioPharma virtual clinical study pilot project in Japan involving the Japan Medical Association Center for Clinical Trials and three general hospitals under Ibaraki Hospital Center of Hitachi. In the pilot, clinical trial contracts and IRB review reports were signed digitally by Astellas as a virtual sponsor and by medical professionals at the hospitals.

Steven Friedman, National Cancer Institute, and Cindy Cullen, Bristol-Myers Squibb, were selected for their participation in a pioneering use of interoperable digital identities by a small group of government and industry cancer researchers that demonstrates how clinical trial initiation can be accelerated while reducing costs.

Peter Alterman, Assistant CIO for EAuthentication, National Institutes of Health, was selected for playing a critical role (as chairman of the Federal PKI Policy Authority) in creating foundational tools for developing and promulgating use of interoperable digital identities by U.S. government employees and for ushering in the era of eSubmissions. The judges also cited Dr. Alterman’s leadership in laying the groundwork for conducting future paperless clinical trials

This is the first of what will become an annual nomination and selection process.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs